Ajax Therapeutics, Inc., A Wholly Owned Subsidiary Of Eli Lilly And Company
Clinical trials sponsored by Ajax Therapeutics, Inc., A Wholly Owned Subsidiary Of Eli Lilly And Company, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for myelofibrosis patients: experimental pill targets resistant disease Results expected Jun 2027 (estimated)